Atlas FDA

Medtronic CoreValve System, Medtronic CoreValve Evolut R System, Medtronic CoreValve Evolut PRO System

FDA premarket approval P130021/S151 · decided 2023-12-23

Approval details

PMA number
P130021
Supplement
S151
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
Medtronic CoreValve System, Medtronic CoreValve Evolut R System, Medtronic CoreValve Evolut PRO System
Generic name
Aortic valve, prosthesis, percutaneously delivered
Applicant
Medtronic, Inc.
Date received
2023-11-30
Decision date
2023-12-23
Days to decision
23 days
Decision code
APPR
Product code
NPT
Advisory committee
Cardiovascular
Expedited review
No
Location
Miinneapolis, MN
Statement
Approval of the revised protocols for the post-approval studies outlined in the approval orders for P130021/S033 and P130021/S058.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
VitalFlow Set with Balance™ Biosurface (K261335)Medtronic, Inc.2026-07-31
Concerto Versa™ Detachable Coil (K261866)Medtronic, Inc.2026-06-24
Elongated One-Piece Arterial (EOPA) 3D™ Arterial Cannulae (K260195)Medtronic, Inc.2026-04-23
Retrograde Coronary Sinus Perfusion Cannulae (K253203)Medtronic, Inc.2026-02-19
Clearview Intracoronary Shunts (K253998)Medtronic, Inc.2026-01-20
Bio-Medicus Life Support Catheter and Introducer (K251831)Medtronic, Inc.2026-01-15
Concerto Versa™ Detachable Coil (K253511)Medtronic, Inc.2026-01-14
C320LBB Delivery System (C320LBBS45), C320LBB Delivery System (C320LBBS48), C320LBB Delivery System (C320LBBL45), C320LBB Delivery System (C320LBBL48) (K253409)Medtronic, Inc.2025-12-19